Serina Therapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Serina Therapeutics, Inc. (SER) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.88 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-15
- Serina Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $1.88M, a 64.10% increase year-over-year.
- Serina Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $1.15M.
- Serina Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$668.00K, a 109.39% decline from fiscal 2017.
- Serina Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $7.12M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|
| 2019-03-31 | $1.88M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$668.00K 10-K · filed 2019-04-01 | |
| 2018-03-31 | $1.15M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $7.12M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |